Deep Learning Market Size Worth $10.2 Billion By 2025

The global deep learning market size is expected to reach USD 10.2 billion by 2025, expanding at a CAGR of 52.1%, according to a new report by Grand View Research, Inc. Considerable improvements in machine learning algorithms and advancements in deep learning chipsets are driving the industry growth.

Rapid improvements in fast information storage capacity, high computing power, and parallelization have contributed to the swift uptake of the deep learning technology in end-use industries such as automotive and healthcare. Further, the need for understanding and analyzing visual contents among enterprises in order to gain meaningful insights, is expected to provide traction to the industry over the forecast period.

The increasing prominence of Graphics Processing Unit (GPU)-accelerated applications is leading to increased adoption of the technology in scientific disciplines such as deep learning and data science. Organizations are utilizing deep learning neural networks to extract valuable insights from enormous amounts of data for providing innovative products and improving customer experience; thereby, increasing revenue opportunities.

The technology is expected to gain prominence among key players and researchers, owing to its use in improvising artificial intelligence capabilities in Natural Language Processing (NLP), image & speech recognition, and computer vision areas. Solution providers are resorting to partnerships and collaborations to enter the deep learning space. For instance, in January 2016, Movidius collaborated with Google, Inc. to enhance its deep learning capabilities on mobile devices. In September 2016, Intel Corporation announced the acquisition of Movidius for improvising its computer vision and deep learning solutions.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/deep-learning-market

Further key findings from the report suggest:

  • The hardware segment is expected to witness the fastest growth due to increased demand for high computing chipsets which are used to run deep learning algorithms
  • The Field Programmable Gate Array (FPGA) segment is expected to witness considerable growth on account of its enhanced power efficiency and capability to bridge the GPU performance gap using multiple FPGAs
  • The healthcare segment is anticipated to grow at a significant rate of over 55%, as the technology is outspreading the translational bioinformatics, medical imaging, and sensor-driven analysis
  • The Asia Pacific deep learning market is expected to be the fastest-growing regional market due to increasing spending on artificial intelligence and cognitive computing technologies
  • The key industry players include Intel Corporation, NVIDIA Corporation, IBM Corporation, and Microsoft Corporation

RFID Technology Market Worth $40.5 Billion By 2025

The global radio frequency identification technology market size is estimated to reach USD 40.5 billion by 2025, expanding at a CAGR of 14.7%, according to a new report by Grand View Research, Inc. The industry is expected to witness a steady growth owing to the increasing demand from the retail sector and the healthcare industry.

RFID technology has been in use for several years now; however, the recent growth in its applications across a wide set of industries, such as retail, transport, medical, and defense, among others, has spurred its adoption. The retail industry is at the forefront and has witnessed its technological reconnaissance with the use of RFID tags. An interesting fact of the retail sector is the way it has successfully passed on the benefits of the technology to other industries in the supply chain with the help of the mandates.

An important aspect of the RFID technology market is the varying nature of manufacturing and evidently the related costs. The past decade has seen a considerable reduction in the production costs with the advent of many new technologies such as printing and ink-jet. As the vendors benefit from these trends in the market, the increasing penetration of cost-to-volume benefits is expected to perpetuate to the end users.

RFID devices are anticipated to witness a surge in demand as the technological proliferation has led to an extensive use of smart cards, access control, and other NFC applications. In addition, the use of Ubiquitous Sensor Networks (USNs) and many short-range wireless communications, such as WiFi and Zigbee, is expected to help in the RFID market growth. To sum up the trends in the market, the RFID industry is anticipated to witness a healthy growth in the coming years with technology, cost, and size fueling its rapid deployment.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/radio-frequency-identification-rfid-technology-market

Further key findings from the report suggest:

  • Government and industry specific mandates are expected to play a vital part in the deployment of RFID devices.
  • The key focus of industry veterans is RFID tags while emphasis laid on frequency bands and size optimization.
  • Numerous research and development activities are being carried out as the industry participants vie for the technological edge.
  • The impact of global technology trends, such as Internet of Things (IoT) and wearables, is prominent on the market and is expected to define the industry’s direction for the next decade.
  • The industry is fragmented in nature and there are several regional and global players operating in the radio frequency identification technology market at various levels of the value chain.

Robotic Prosthetic Market Worth $2.1 Billion By 2027

The global robotic prosthetic market size is anticipated to reach USD 2.1 billion by 2027, expanding at a CAGR of 9.2%, according to a new report by Grand View Research, Inc. Increasing cases of amputation, advancements in robotic space, and a rise in the number of ulcers, diabetes, and congenital abnormalities that lead to amputation are estimated to drive growth over the forecast period. Moreover, increasing government funding and innovations in robotic space are anticipated to drive growth over the forecast period.

Based on technology used, the market is segmented into MPC Prosthetics and Myoelectrical Prosthetics. MPC technology dominated the market in 2019, and is forecasted to grow at a lucrative rate over the forecast period. Whereas, Myoelectrical prosthetics is anticipated to be the fastest-growing segment during the forecast period. The prosthetics operate on electric power, without putting any extra stress or muscle tension on the wearer. This advantage of Myoelectrical technology over MPC is anticipated to drive segment growth over the forecast period.

Based on the extremity, the robotic prosthetic market is segmented into upper extremity and lower extremity. Lower extremity dominated the market in 2019, and is also expected to grow at the fastest rate over the forecast period. Increasing amputations of the lower limb owing to the high incidence of the diabetic foot and vascular diseases are anticipated to drive segment growth. Moreover, the launch of innovative products by major players is further anticipated to drive growth over the forecast period.

North America dominated the market in 2019, with a revenue share of 43.5%. Major factors driving the growth are increasing healthcare expenditure, improvements in robotic space and favorable government initiatives with regards to supporting robotic technology in U.S. are the major factors driving the growth. Asia Pacific is anticipated to be the fastest-growing region, owing to the growing investments in the robotic field and rising healthcare expenditure.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/robotic-prosthetics-market

Further key findings from the report suggest:

  • The market is anticipated to reach USD 2.07 billion by 2027, owing to the advancements in robotic space
  • The myoelectric prosthetics segment is expected to be the fastest growing with a CAGR of 10.3%, as it operates on electric power without stressing the wearer
  • Lower extremity dominated the space in 2019 with a CAGR of 9.5%, owing to the increasing number of lower limb amputation and growing prevalence of diabetic foot
  • North America dominated the robotic prosthetic market in 2019 with a value of USD 454.9 million, as the adoption of technologically advanced products in the region is high
  • Some of the key players are Ottobock; Touch Bionics, Inc.; Shadow Robot Company; and HDT Global.

Viscosupplementation Market Worth $7.8 Billion By 2027

The global viscosupplementation market size is expected to reach USD 7.8 billion by 2027, based on a new report published by Grand View Research, Inc. It is anticipated to exhibit a CAGR of 9.2% during the forecast period. Improving regulatory and reimbursement scenarios regarding the use of viscosupplements for the treatment of Osteoarthritis (OA) is expected to aid the growth. For instance, in U.S., unique reimbursement codes are allocated for different products available in the country.

Viscosupplementation procedure is an effective alternative for patients nonresponsive to other treatment options for osteoarthritis. These products have been clinically proven to be effective in providing long-term relief to OA patients with very few side-effects. Factors, such as the growing awareness regarding effective non-surgical procedures for the management of OA and global increase in the target population due to the increasing prevalence of obesity and other lifestyle-induced disorders, are expected to propel the market growth during the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/viscosupplementation-market

Further key findings from the study suggest:

  • Three injections segment dominated the market in 2019 owing to the availability of multiple products and significant market presence
  • Single injection segment is anticipated to witness the fastest growth during the forecast period owing to the increase in demand for a shorter regimen of procedures and faster recovery time
  • The utilization of viscosupplementation is maximum in Ambulatory Surgical Centers (ASCs), and orthopedic clinics. The higher usage of the viscosupplements is observed to be in outpatient settings owing to better reimbursement options
  • General physicians, rheumatologists, and orthopedists are the main influencer in the viscosupplementation market. The role of an influencer in the procurement of the product in the hospitals and clinics varies from region to region
  • Asia Pacific held the largest market share in 2019 and is expected to maintain its position during the forecast period due to the presence of key players and high incidence of osteoarthritis in the countries such as Japan and China.
  • Europe is expected to witness a lucrative CAGR in the forthcoming years, due to growing awareness about applications of non-surgical techniques and increasing disposable income
  • Key players are investing in improving their product portfolio to develop advanced products to maintain their market position. For instance, in March 2019, Seikagaku Corporation introduced a new intra-articular viscosupplement named HyLink (single injection) in Italy for the treatment of knee OA
  • Companies are also undertaking strategic initiatives, such as marketing licensing and distribution partnerships to increase geographic presence
  • Some key industry contributors are Anika Therapeutics, Inc.; Sanofi; Ferring B.V.; Seikagaku Corporation; Bioventus; Zimmer Holdings Inc; LG Life Sciences Ltd; and Lifecore Biomedical, LLC

Spirometer Market Size Worth $1.7 Billion By 2027

The global spirometer market size is expected to reach USD 1.7 billion in 2027, according to a new report by Grand View Research, Inc. The market is expected to expanding at a CAGR of 9.7% from 2020 to 2027. The prevalence of chronic respiratory diseases is rising among adults as well as children across the globe. The guidelines for the diagnosis and treatment of asthma in children and the Global Initiative on Asthma (GINA) guidelines recommend the usage of spirometry more frequently for asthma. GINA published a 2020 update for Global Strategy for Asthma Management and Prevention, which includes information about asthma after reviewing the scientific literature and contains citations from the scientific literature.

Technological advancements are leading to the development of innovative spirometers. Manufacturers are involved in the launch of technologically advanced products. For instance, in March 2018, a Swedish startup, NuvoAir, launched a handheld spirometer called Air Next. These palm-size spirometers are specially designed for home use and use Bluetooth wireless technology.

Amid the COVID-19 pandemic, manufacturers are witnessing a boost in product demand from healthcare professionals as well as patients to monitor their lung functions at home. Technologically advanced respiratory health management companies have developed digital spirometers that enable patients to easily monitor their lung function. For instance, in April 2020, Aluna, a San Francisco-based company, launched its FDA-approved portable digital spirometer, helping patients monitor their lung health at home.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/spirometer-market

Further key findings from the study suggest:

  • Table top spirometers dominated the type segment in terms of revenue share in the year 2019 as the device is widely used in the diagnosis of obstructive airway disorders
  • Desktop spirometers are likely to witness the fastest growth over the forecast period as the computer-based spirometry supports in making enhanced clinical decisions based on integrated clinical information
  • The flow measurement technology segment dominated the market in terms of revenue share in 2019 due to extensive use in pulmonary function testing. Peak flow measurement spirometers are expected to register the fastest growth over the forecast period
  • Based on application, Chronic Obstructive Pulmonary Disease (COPD) held the majority of the market share in 2019 pertaining to the high prevalence of mild to severe COPD. Whereas the asthma segment is expected to grow at the fastest rate during the forecast period due to the increasing prevalence of the disease and high treatment cost
  • In the end-use segment, hospitals and clinics held the largest market share in 2019 due to the extensive use of spirometry for diagnosis and monitoring of chronic respiratory disorders. However, the home healthcare segment is likely to experience an impressive growth rate in the coming years due to the adoption of telemedicine and the launch of new products
  • North America dominated the market in terms of revenue share in 2019 due to the high prevalence of COPD in the U.S. On the other hand, in the Asia Pacific, the market is expected to showcase the fastest growth rate due to the improving primary care initiatives for early diagnosis and management of chronic lung diseases such as asthma and COPD

Veterinary Surgical Instrument Market Size Worth $1.5 Billion By 2027

The global veterinary surgical instrument market size is expected to reach USD 1.5 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.0% from 2020 to 2027. Growing demand for pet adoption is expected to drive the market over the forecast period. Increasing income in developing countries is another driving factor. For instance, according to a report by the American Veterinary Medical Association (AVMA) in 2017, around 46.0% of households had multiple types of pets in the U.S. Furthermore, key players are implementing newer strategies to sustain in this competitive market. For instance, in March 2019, Bruhat Bengaluru Mahanagara Palike (BBMP) in India planned to introduce a rescue ambulance to rescue injured animals for faster treatment. The ambulance will be equipped with all the necessary tools such as surgical instruments and sterilizers.

Moreover, technological advancements in surgical devices and the availability of a number of detection techniques are anticipated to create growth opportunities in the market. These include microfracture detection, laparoscopy, and 3D printing. For instance, in October 2017, Surgical Holdings launched two new product-chisels and osteotomes-to expand its product portfolio.

The global veterinary surgical instrument market is highly competitive in nature. It is dominated by participants such as B. Braun Vet Care GmbH, Medtronic, Jorgen Kruuse A/S, and SurgiVet. Market players focus on adopting strategies such as new product launches, partnerships, and collaborations. For instance, in July 2018, B. Braun Vet Care signed an agreement to deal with CP Medical wherein the company will distribute B. Braun’s veterinary Infusion Therapy product line in the U.S. and Canada.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/veterinary-surgical-instruments-market

Further key findings from the report suggest:

  • An increasing number of veterinary practitioners are anticipated to create growth opportunities in the market
  • Handheld devices accounted for the largest share in 2019, owing to their use for multiple purposes and ease of handling
  • The small animal segment is expected to exhibit lucrative growth over the forecast period owing to rising incidences of pet adoption and increased demand for efficient care
  • The dental surgery segment held the largest share in 2019 due to the increasing prevalence of periodontal diseases and rising demand for pet dental care
  • North America dominated the global market in 2019 due to favorable pet insurance policies and new product launches by companies. However, Asia Pacific is anticipated to exhibit the most lucrative growth rate over the forecast period owing to the rising demand for pet adoption and increasing disposable income, particularly in Japan and India
  • Some of the key companies in the market are Medtronic, DRE Veterinary, B. Braun Vet Care GmbH, and Jorgen Kruuse A/S.

Women’s Health Market Size Worth $47.8 Billion By 2027

The global women’s health market size is expected to reach USD 47.8 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 4.9% over the forecast period. Governments and various private organizations focused on women health across the globe, which is likely to drive the market in the coming years. Coverage plans provided to women is one of the key factors expected to drive the market in developed countries.

In U.S., coverage plans provide preventive services for women without any copayment charges. This includes anemia screening on a routine basis, folic acid supplements for women who may become pregnant, hepatitis B screening, breast cancer screening, and contraception. Healthy People 2020 was established by the Department of Health and Human Services which has a 10-year agenda for improving the health of all Americans.

Initiatives undertaken by countries such as India, Japan, China, Singapore, and Australia are expected to drive the market over the forecast period. For example, in September 2016, Australia’s Ministry of Health provided a grant of USD 3.8 million till 2019 to Jean Hailes, a women’s health group, to help develop its education and outreach.

Owing to aging and rising incidences of obesity, an increase in prevalence of osteoarthritis (OA) has been witnessed. According to the United Nations, about 10%-15% of all adults aged over 60 have some degree of OA, and the condition is more prevalent in women. According to the CDC, in 2013, back problems were more common in women (30.2%). According to the International Osteoporosis Foundation (IOF), the worldwide prevalence of osteoporosis among women was over 200.0 million in 1990, which is anticipated to reach 680.0 million by 2050.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/womens-health-market

Further key findings from the study suggest:

  • On the basis of application, the women’s health market is segmented into postmenopausal osteoporosis, endometriosis, hormonal  infertility, contraceptives, and polycystic ovary syndrome (PCOS) and menopause. Contraceptives held a majority of the market share in terms of revenue in 2019
  • Availability of a wide range of drugs for the treatment of postmenopausal osteoporosis is projected to boost the market. These include Fosamax, Actonel, Boniva, Reclast, Evista, and Prolia. In April 2017, the U.S. FDA approved a new drug, Tymlos, to treat postmenopausal osteoporosis. The approval was based on data of an 18-month trial that demonstrated a substantial reduction in the risk of vertebral and non-vertebral fractures
  • North America held the largest market share in 2019 owing to technological advancements and presence of major market players in the region. Asia Pacific, on the other hand, is expected to witness the highest growth rate over the forecast period
  • Some of the key players in the women’s health market are Bayer AG; Allergan; Merck & Co., Inc.; Teva Pharmaceuticals; Pfizer; Agile Therapeutics; Amgen, Inc.; AstraZeneca, Bristol-Myers Squibb, and Ferring B.V.

Cord Blood Banking Services Market Size Worth $82.3 Billion By 2025

The global cord blood banking services market is expected to reach over USD 82.3 billion by 2025, growing at an estimated CAGR of around 11.9% from 2017 to 2025, according to a new study by Grand View Research, Inc. Key drivers of the market include increasing application of stem cell therapies in disease treatment, and rising prevalence of life threatening genetic disorders.

Moreover, increasing spending capacity is fueling the demand for advanced healthcare facilities including disease prevention and treatment. As a result, parents are increasingly demanding CBB services to ensure safety of their child’s future. Furthermore, private players are practicing marketing activities which are creating awareness about the availability of the CBB services and their benefits.

In addition, governments worldwide are promoting public CBB to develop ethnically diverse cord blood repository which would increase the chances of finding suitable human leukocyte antigen (HLA) match for the patients. As a result, availability of the ethnically rich CB repository coupled with anticipated rise in the stem cell therapies and bone marrow transplants, is expected to spur the CBB services during the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cord-blood-banking-services-market

Further Key Findings From the Report Suggest:

  • Private bank segment accounted for the largest revenue share in 2016. High cost of collection, processing, and storage along with the maximum awareness created by marketing activities practiced by the players resulted in large revenue share of private banks across the globe. 
  • Rising government support and no storage and collection costs are the major factors anticipated to drive the public banking sector during the forecast period from 2017 to 2025 with highest CAGR.  
  • North America dominated the global market and was followed by Europe in 2016. Dominance of North America is owing to government support and high rate of stem cell therapy in the U.S. and Canada.
  • Moreover, high awareness and insurance coverage of cord blood banking and stem cell therapies is further boosting the growth of the market in North America
  • Densely populated emerging countries of Asia Pacific are anticipated to show significant growth during the forecast period from 2017 to 2025.
  • Factors such as increasing investment by global players, government support and rising healthcare expenditure are anticipated to boost the cord blood banking services market in Asia Pacific
  • Global CBB services sector is highly fragmented with presence of many private and public players. Few global players operate in various geographies through subsidiaries. While local players are operating independently in respective geographies.
  • Key players of this market include China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Limited, Cryo-Cell International, Inc., Cryo-Save AG, Lifeforce Cryobanks, National Cord Blood Program, ViaCord, Inc. and Virgin Health Bank

Protein Expression Market Worth $3.0 Billion By 2025

The global protein expression market is expected to reach USD 3.0 billion by the year 2025 growing at a CAGR of 10.4%, according to a new report by Grand View Research, Inc. The growing demand for biologics and expansion of the biopharmaceutical industry have resulted in massive growth of the protein expression market. Rising demand for therapeutic proteins such as insulin, hormones, monoclonal antibodies, and vaccines is a major factor that propels growth of the market during forecast period. Thus, many biotechnology and pharmaceuticals companies have begun to concentrate on the development and manufacturing of advanced therapeutic proteins for the treatment of severe chronic diseases such as cancer, hemophilia, infectious diseases, anemia, and multiple sclerosis.

Increasing investment in the R&D, by biotechnology and pharmaceutical companies, is another major factor supporting the sector growth. The availability of new and advanced technologies to cater the needs of drugs & biologics product manufacturers boosts the adoption of protein expression products for research and manufacturing applications. In addition, several pharmaceutical and biotechnology manufacturers are undergoing collaborations and partnerships to achieve leadership in the sector. For instance, in December 2016, Takara Bio, Inc. signed a merger agreement with Rubicon Genomics, Inc. to strengthen its genomics business.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/protein-expression-market

Further Key Findings From The Report Suggest:

  • Prokaryotic expression systems segment was the largest revenue-generating amongst others owing to its large application in biologics and drug productions
  • Mammalian cell expression systems is the fastest growing segment of the protein expression market owing to its growing demand for proteomics research and biologics manufacturing
  • Reagents segment held the largest revenue share in the market, which is attributed to its repetitive purchase for therapeutic, industrial, and research applications
  • The services segment is projected to grow at highest rate due to increasing trend of outsourcing of protein expression services by research labs and drug manufacturers
  • Therapeutic application segment was leading in 2016, due to high demand of therapeutic proteins for the treatment of cancer, infectious diseases, anemia, hemophilia, and multiple sclerosis
  • The pharmaceutical and biotechnological companies segment dominated the sector in terms of revenue in 2016 due to rising focus on proteomics research and increasing production of biologics products
  • North America was the leading regional market in 2016 and is expected to maintain its dominance during the forecast period, because of the presence of large number of biopharmaceutical and biotechnology companies in this region
  • The Asia Pacific region is projected to grow at a highest CAGR during the forecast period owing to untapped opportunities in the developing countries including China and India
  • Some of the major players include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Merck KGaA, New England Biolabs, Promega Corporation, Qiagen, and Takara Bio, Inc.

Cancer Stem Cells Market Worth $1.6 Billion By 2025

The global cancer stem cells market size is expected to reach USD 1.6 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.98% during the forecast period. Although stem cell-based cancer treatment is facing regulatory and ethical challenges, the market is growing worldwide. With increasing awareness about these cells, there is steady growth in the R&D for the development of effective and novel treatment methods based on stem cells.

Furthermore, continuous rise has been observed in the number of research studies on cancer stem cells (CSCs) being published. These studies have helped healthcare professionals gain insights into CSCs biology and their signaling pathways. This is expected to create tremendous growth prospects for the market.

Furthermore, improvements in experimental approaches, in particular, in vitro assay systems have enabled scientists to establish relationship between different cell types in a tumor and their microenvironment. This has led to development of a broad therapeutic portfolio for CSCs and their associated key pathways for restricting growth of the tumor and providing improved clinical outcome.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cancer-stem-cells-market

Further key findings from the report suggest:

  • The anti-CSC therapeutics segment accounted for a significant share owing to increasing R&D activities for the development of novel therapeutics
  • Anti-CSCs therapeutics/agents include agents that target key pathways, surface markers, immuno-evasion & tumor microenvironment, along with nanoparticle-based therapies. As key pathways play a major role in tumor regulation, pathway inhibitors captured the largest share owing to the presence of a broad portfolio of products under pipeline
  • With rising prevalence of bladder cancer, the segment is expected to exhibit the highest CAGR of 10.47% during the forecast period
  • North America held the largest share in 2016 owing to presence of a large number of facilities in the U.S. that offer stem cell services
  • Asia Pacific is likely to emerge as the fastest growing regional market owing to increasing investments by various agencies to accelerate research activities in Asian countries
  • Some of the prominent players in the market are Thermo Fisher Scientific, Inc.; AbbVie, Inc.; Merck KGaA; Bionomics; and Lonza.